(Q42499996)

English

Insulin resistance, endocrine function and adipokines in type 2 diabetes patients at different glycaemic levels: potential impact for glucotoxicity in vivo

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Insulin resistance, endocrine function and adipokines in type 2 diabetes patients at different glycaemic levels: potential impact for glucotoxicity in vivo (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

type 2 diabetes

0 references

insulin resistance

1 reference

based on heuristic

inferred from title

author name string

Lindmark S

1

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Burén J

2

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Eriksson JW

3

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

publication date

1 September 2006

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Clinical Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

65

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

301-309

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02593.X

21 January 2018

Endocrine abnormalities in healthy first-degree relatives of type 2 diabetes patients--potential role of steroid hormones and leptin in the development of insulin resistance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02593.X

21 January 2018

In vitro reversal of hyperglycemia normalizes insulin action in fat cells from type 2 diabetes patients: is cellular insulin resistance caused by glucotoxicity in vivo?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02593.X

21 January 2018

Neuroendocrine perturbations as a cause of insulin resistance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02593.X

21 January 2018

Glucocorticoids and insulin resistance: old hormones, new targets

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02593.X

21 January 2018

Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02593.X

21 January 2018

Glucotoxicity and beta-cell failure in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02593.X

21 January 2018

Acute and chronic effects of hyperglycaemia on glucose metabolism: implications for the development of new therapies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02593.X

21 January 2018

How to measure insulin sensitivity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02593.X

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02593.X

21 January 2018

A low dose ACTH test to assess the function of the hypothalamic-pituitary-adrenal axis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02593.X

21 January 2018

Abnormal glucocorticoid activity in subjects with risk factors for cardiovascular disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02593.X

21 January 2018

Type 2 diabetes as a lipid disorder.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02593.X

21 January 2018

Relationships between plasma-free fatty acid concentration, endogenous glucose production, and fasting hyperglycemia in normal and non-insulin-dependent diabetic individuals.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02593.X

21 January 2018

Vasoconstrictor response to topical beclomethasone in major depression.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02593.X

21 January 2018

Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02593.X

21 January 2018

The role of TNF alpha in adipocyte metabolism.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02593.X

21 January 2018

Regulation of the HPA axis by cytokines

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02593.X

21 January 2018

Subclinical inflammation in newly detected Type II diabetes and impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02593.X

21 January 2018

CRP and IL-6 concentrations are associated with poor glycemic control despite preserved beta-cell function during the first year after diagnosis of type 1 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02593.X

21 January 2018

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02593.X

21 January 2018

Adipose-cell size and immunoreactive insulin levels in obese and normal-weight adults

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02593.X

21 January 2018

Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02593.X

21 January 2018

Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02593.X

21 January 2018

Minireview: 11beta-hydroxysteroid dehydrogenase type 1- a tissue-specific amplifier of glucocorticoid action

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02593.X

21 January 2018

Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02593.X

21 January 2018

Effect of hyperglycemia and hyperinsulinemia on the response of IL-6, TNF-alpha, and FFAs to low-dose endotoxemia in humans

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02593.X

21 January 2018

Effects of glycaemia on glucose transport in isolated skeletal muscle from patients with NIDDM: in vitro reversal of muscular insulin resistance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02593.X

21 January 2018

Identifiers

10.1111/J.1365-2265.2006.02593.X

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42499996&oldid=1959920084"